Floatz logo

Huazhi Rougan Granule

Efficacy and Safety

Shandong New Time Pharmaceutical Co., LTDPhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Efficacy and Safety cohort.

Asset / SponsorPhaseRating
Carboplatin
Women's Hospital School Of Medicine Zhejiang University
Phase 4BB
Inno-206
Women's Hospital School Of Medicine Zhejiang University
Phase 4BB
Rivoceranib
Rongjie Tao
Phase 2B
Calcium folinate pentahydrate
The First Affiliated Hospital with Nanjing Medical University
Phase 2CCC
Toripalimab
Sun Yat-sen University
Phase 2CCC

View all 14 →

Same molecule, other indications

Huazhi Rougan Granule is also rated in:

Helicobacter pylori infection, susceptibility toDormant
D
Indicative ·
30 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
D
Indicative ·
30 / 100
View asset →
liver disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →